Status
Conditions
Treatments
About
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
Full description
Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection and correlation between the severity of covid-19 and TE.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Umut Mert YILDIRIM, Dr.; Hasan AKSOY, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal